News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
HULME ALLISON
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2023 |
4
| HULME ALLISON (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/12/2023 |
4
| HULME ALLISON (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Granted 12,880 options to buy
@ $34.16, valued at
$440k
|
|
01/12/2023 |
3
| HULME ALLISON (Director) has filed a Form 3 on Ventyx Biosciences, Inc. |
12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2019 |
4
| HULME ALLISON (COO) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 245,000 options to buy
@ $0.83, valued at
$203.4k
|
|
12/08/2017 |
4
| HULME ALLISON (COO) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 8,000 options to buy
@ $1.91, valued at
$15.3k
|
|
12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/01/2016 |
4
| HULME ALLISON (COO) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 103,467 options to buy
@ $0.99, valued at
$102.4k
|
|
02/06/2015 |
4
| HULME ALLISON (COO) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 45,481 options to buy
@ $0.4589, valued at
$20.9k
|
|
10/29/2013 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
|
|